NeurAxis, Inc. (NRXS)

ASE – Цена в реальном времени. Валюта: USD

7.27

+0.36 (5.21%)

При закрытии: Jun 26, 2026, 4:00 PM EDT

7.37

+0.10 (1.38%)

После закрытия: Jun 26, 2026, 7:28 PM EDT

15.05.2026

NeurAxis Stock Gains Post Q1 Earnings, Revenues and Margin Surge Y/Y

NRXS' first-quarter 2026 results show surging revenue and expanding gross margin as reimbursement improves under the Category I CPT code.

12.05.2026

NeurAxis, Inc. (NRXS) Q1 2026 Earnings Call Transcript

12.05.2026

NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth

CARMEL, Ind., May 12, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced results for the first quarter period ended March 31, 2026.

05.05.2026

NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026

CARMEL, Ind., May 05, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, will report summarized financial results for its first quarter 2026, for the period ended March 31, 2026, on Tuesday, May 12, 2026, before market open. The Company has scheduled a conference call for the same day, Tuesday, May 12, 2026, at 9:00 am ET to review the results.

22.04.2026

NeurAxis Expands Payer Coverage with Four New Medical Policies

CARMEL, Ind., April 22, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced four additional health insurers with medical policy coverage for Percutaneous Electrical Nerve Field Stimulation (PENFS), representing approximately 1.25 million covered lives. These medical policies expand incremental access to IB-Stim treatment for beneficiaries in West Virginia, New Hampshire, South Carolina, Virginia, and Florida.

10.04.2026

NeurAxis, Inc. Announces Preferred Stock Dividend

CARMEL, Ind., April 10, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced that on April 10, 2026, its Board of Directors declared a dividend on its Series B Preferred Stock.

24.03.2026

NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth

NRXS witnesses strong revenue growth and expanding coverage in fourth-quarter 2025, but rising costs and commercialization investments weigh on profitability.

Видео

No Data

There is no data to display

Пресс-релизы

12.05.2026

NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth

22.04.2026

NeurAxis Expands Payer Coverage with Four New Medical Policies

10.04.2026

NeurAxis, Inc. Announces Preferred Stock Dividend

19.03.2026

NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results

CARMEL, Ind., March 19, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today announced results for the fourth quarter period and full year ended December 31, 2025.

NeurAxis, Inc. (NRXS)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

NeurAxis, Inc. (NRXS)

NeurAxis Stock Gains Post Q1 Earnings, Revenues and Margin Surge Y/Y

NeurAxis, Inc. (NRXS) Q1 2026 Earnings Call Transcript

NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth

NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026

NeurAxis Expands Payer Coverage with Four New Medical Policies

NeurAxis, Inc. Announces Preferred Stock Dividend

NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth

Видео

No Data

Пресс-релизы

NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth

NeurAxis Expands Payer Coverage with Four New Medical Policies

NeurAxis, Inc. Announces Preferred Stock Dividend

NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results

NeurAxis Stock Gains Post Q1 Earnings, Revenues and Margin Surge Y/Y

NeurAxis, Inc. (NRXS) Q1 2026 Earnings Call Transcript

NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth

NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026

NeurAxis Expands Payer Coverage with Four New Medical Policies

NeurAxis, Inc. Announces Preferred Stock Dividend

NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth

Видео

No Data

Пресс-релизы

NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth

NeurAxis Expands Payer Coverage with Four New Medical Policies

NeurAxis, Inc. Announces Preferred Stock Dividend

NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results

Search stocks

NeurAxis, Inc. (NRXS)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

NeurAxis, Inc. (NRXS)

NeurAxis Stock Gains Post Q1 Earnings, Revenues and Margin Surge Y/Y

NeurAxis, Inc. (NRXS) Q1 2026 Earnings Call Transcript

NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth

NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026

NeurAxis Expands Payer Coverage with Four New Medical Policies

NeurAxis, Inc. Announces Preferred Stock Dividend

NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth

Видео

No Data

Пресс-релизы

NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth

NeurAxis Expands Payer Coverage with Four New Medical Policies

NeurAxis, Inc. Announces Preferred Stock Dividend

NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results

NeurAxis Stock Gains Post Q1 Earnings, Revenues and Margin Surge Y/Y

NeurAxis, Inc. (NRXS) Q1 2026 Earnings Call Transcript

NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth

NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026

NeurAxis Expands Payer Coverage with Four New Medical Policies

NeurAxis, Inc. Announces Preferred Stock Dividend

NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth

Видео

No Data

Пресс-релизы

NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth

NeurAxis Expands Payer Coverage with Four New Medical Policies

NeurAxis, Inc. Announces Preferred Stock Dividend

NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results